Literature DB >> 12471777

Diagnosis of hypogonadism in the aging male.

A Vermeulen1, J M Kaufman.   

Abstract

The diagnosis of hypoandrogenism in the aging male is still difficult, since the symptomatology is aspecific and multifactorial, and it is unknown whether the androgen requirements of elderly men are the same as those of young men. Indeed, there are arguments for decreased (increased androgen feed-back sensitivity) as well as for increased (decreased concentration of androgen receptors) requirements in elderly men. In the absence of a reliable, clinically useful, parameter of androgen activity, we have to rely on plasma androgen level, an indirect parameter. In the absence of convincing arguments for altered requirements with age, we consider that the normal range of (free) testosterone levels in young adults is also valid for elderly men, the lower normal limit being 11 nmol/l for total testosterone and 0.225 nmol/l for free testosterone. There are indirect, suggestive clinical arguments for accepting these limit values. The diagnosis of hypoandrogenism in elderly males requires both the presence of clinical symptoms and decreased (free) testosterone levels. The best methods for determining free or bioavailable testosterone, are equilibrium dialysis and ammonium sulfate precipitation, respectively. They are, however, time-consuming techniques which are not easily automated. Calculation of the free androgen index (testosterone/sex hormone binding globulin (SHBG)) is not a valid method for male serum. Calculation of free testosterone from total testosterone, SHBG and albumin concentration, yields values that are in good agreement with values obtained by dialysis or ammonium sulfate precipitation. Several conditions should, however, be fulfilled: reliable methods for the determination of testosterone and SHBG, SHBG measurement in serum and not in plasma, use of fresh serum (not repeatedly frozen and thawed), absence of (exogenous) steroids competing for binding sites on SHBG and blood samples taken between 08.00 and 10.00 in the fasting state. Under these conditions an excellent correlation with dialysis and bioavailable testosterone (ammonium sulfate precipitation) is generally obtained.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12471777

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  22 in total

1.  Sex hormones differentially influence voluntary running activity, food intake and body weight in aging female and male rats.

Authors:  J Andries Ferreira; Andrea M Foley; Marybeth Brown
Journal:  Eur J Appl Physiol       Date:  2011-12-15       Impact factor: 3.078

2.  Extracellular signal-regulated kinase 2 signaling in the hippocampal dentate gyrus mediates the antidepressant effects of testosterone.

Authors:  Nicole Carrier; Mohamed Kabbaj
Journal:  Biol Psychiatry       Date:  2012-01-20       Impact factor: 13.382

3.  Diagnosis of hypogonadism: clinical assessments and laboratory tests.

Authors:  Christina Carnegie
Journal:  Rev Urol       Date:  2004

4.  Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer.

Authors:  Matthew R Smith
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

5.  Testosterone and imipramine have antidepressant effects in socially isolated male but not female rats.

Authors:  Nicole Carrier; Mohamed Kabbaj
Journal:  Horm Behav       Date:  2012-03-09       Impact factor: 3.587

6.  The association between serum testosterone and mortality among elderly men on hemodialysis.

Authors:  Hung-Chieh Wu; Lin-Chien Lee; Wei-Jie Wang
Journal:  J Clin Lab Anal       Date:  2018-01-25       Impact factor: 2.352

7.  Serum testosterone levels using the radioimmunoassay method in healthy Japanese male volunteers.

Authors:  Yoshikazu Sato; Hitoshi Tanda; Shuji Kato; Shigeki Onishi; Hisao Nakajima; Akihito Nanbu; Toshikazu Nitta; Mikio Koroku; Keigo Akagashi; Tatsuo Hanzawa; Tadatoshi Shinozaki; Naoaki Terao; Nobuta Fujisaki; Morimasa Kuwabara; Kenji Niimura
Journal:  Reprod Med Biol       Date:  2006-03-01

Review 8.  Depression in aging men: the role of testosterone.

Authors:  Ryan M Carnahan; Paul J Perry
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Low serum testosterone increases mortality risk among male dialysis patients.

Authors:  Juan Jesús Carrero; Abdul Rashid Qureshi; Paolo Parini; Stefan Arver; Bengt Lindholm; Peter Bárány; Olof Heimbürger; Peter Stenvinkel
Journal:  J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 10.121

Review 10.  A new oral testosterone undecanoate formulation.

Authors:  Frank-Michael Köhn; Wolf-Bernhard Schill
Journal:  World J Urol       Date:  2003-10-25       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.